AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MARTIUS, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by MARTIUS, C.
Agricola
Right arrow Articles by MARTIUS, C.

American Journal of Clinical Nutrition, Vol 9, 97-103, Copyright © 1961 by The American Society for Clinical Nutrition, Inc.

The Metabolic Relationships between the Different K Vitamins and the Synthesis of the Ubiquinones

CARL MARTIUS PH.D.1

1 From the Eidg. Technische Hochschule, Laboratorium für Biochemie, Zürich, Switzerland

Methylnaphthoquinone is converted in the animal organism into vitamin K2(20), which is the actual active form of the K vitamins. Vitamin K1 (phylloquinone) as well as vitamin K2(30) (the K vitamin of bacteria) first lose the side chain and are thus converted into methylnaphthoquinone, which then yields vitamin K2(20). The side chain can be introduced in vitro in the presence of an enzyme system which occurs in liver mitochondria. The action of the enzyme system consists of condensing the pyrophosphates of isoprenalkohols with the quinone with elimination of pyrophosphoric acid and formation of the corresponding 3-substituted naphthoquinones.

It has been shown that the synthesis of the ubiquinones (coenzyme A) takes place along the same lines, starting from 2,3-dimethoxy-5-methyl-benzoquinone.

The properties of a new flavoprotein (vitamin K reductase) are described. This reductase transfers hydrogen from DPNH+ and TPNH+ to various quinones and is strongly inhibited by vitamin K antagonists (e.g., dicumarol). The importance of this enzyme for the interpretation of the mechanism of action of vitamin K is discussed.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1961 by The American Society for Nutrition